Not Tagged
Not Tagged
[]
op0074 lorecivivint wnt pathway modulation drug on strides x-ray study, knee oa. single-blinded and ol extension. some diff at 12-24months (no diff at 0-12 months). no diff in pain, some change in womac pain. #eular2023
Rheumatologist and Assistant Professor of Rheumatology at CAML. Sjögren Disease Coordinator for ERN-ReCONNET. MedEd, emotional learning & mental health advocate